secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0001193125-25-047165
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio enters 5-year supply agreement with Asymchem for taletrectinib drug substance
--------------------------------------------------------------------------------

- Asymchem will be a non-exclusive supplier; Nuvation retains right to use alternate manufacturers.
- Initial term of 5 years, auto-renews for 3-year periods unless either party gives 6-month nonrenewal notice.
- Orders must be placed at least 180 days before delivery; cancellations incur tiered percentage fees.
- Company may terminate without cause on 30 days' notice; either party may terminate for material breach or insolvency.
- Agreement covers delivery, quality, IP, confidentiality, and indemnification; financial terms not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525047165/0001193125-25-047165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525047165/d876513d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-047165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer